Maki Nagashima
- Epidemiology
- Molecular Medicine top 10%
- Pulmonary and Respiratory Medicine
- Infectious Diseases
- Molecular Biology
- Co-authors
- Akira OhnoKazuhiro TatedaToshiyuki MatsunagaS MiyazakiYoshikazu IshiiNobuhiko FuruyaK YamaguchiTetsuya Matsumoto
- Topics
- Antibiotic Resistance in Bacteria (7 papers)Bacterial Identification and Susceptibility Testing (4 papers)Pneumonia and Respiratory Infections (3 papers)
- Partner nations
- JapanUnited StatesVietnam
In The Last Decade
Maki Nagashima
20 papers receiving 199 citations
Peers
Comparison fields: 5 of 62
- Epidemiology 73
- Molecular Medicine 57
- Pulmonary and Respiratory Medicine 56
- Infectious Diseases 47
- Molecular Biology 41
Countries citing papers authored by Maki Nagashima
This map shows the geographic impact of Maki Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Nagashima more than expected).
Fields of papers citing papers by Maki Nagashima
This network shows the impact of papers produced by Maki Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Nagashima. The network helps show where Maki Nagashima may publish in the future.
Co-authorship network of co-authors of Maki Nagashima
This figure shows the co-authorship network connecting the top 25 collaborators of Maki Nagashima. A scholar is included among the top collaborators of Maki Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maki Nagashima. Maki Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 11 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 9 | |
| 12 | 12 | |
| 13 | 6 | |
| 14 | 19 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 4 |
About Maki Nagashima
Maki Nagashima is a scholar working on Microbiology, Molecular Medicine and Clinical Biochemistry, having authored 25 papers that have together received 202 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (57 citations), Applied Microbiology and Biotechnology (12 citations) and Endocrinology (16 citations). Maki Nagashima has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Akira Ohno, Kazuhiro Tateda, Toshiyuki Matsunaga, S Miyazaki, Yoshikazu Ishii, Nobuhiko Furuya, K Yamaguchi, Tetsuya Matsumoto, Kayoko Hayakawa and Norio Ohmagari. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.